Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SRSF12 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
mRNA | MBD3 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | HOMER1 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
mRNA | PIF1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | B3GALT1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | PATE4 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
mRNA | IMPG1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
mRNA | HAT1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
mRNA | C1R | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | HSPD1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |